Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

p53 further extends its reach.

Zirngibl K, Moll UM.

Oncoimmunology. 2013 May 1;2(5):e24959. No abstract available.

2.

Neuronal expression of p53 dominant-negative proteins in adult Drosophila melanogaster extends life span.

Bauer JH, Poon PC, Glatt-Deeley H, Abrams JM, Helfand SL.

Curr Biol. 2005 Nov 22;15(22):2063-8.

3.

Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice.

Komarova EA, Antoch MP, Novototskaya LR, Chernova OB, Paszkiewicz G, Leontieva OV, Blagosklonny MV, Gudkov AV.

Aging (Albany NY). 2012 Oct;4(10):709-14.

4.
5.

Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53.

Eischen CM, Boyd K.

PLoS One. 2012;7(9):e46148. doi: 10.1371/journal.pone.0046148. Epub 2012 Sep 28.

6.

The temperature sensitive mutant p53-143ala extends in vitro life span, promotes errors in DNA replication and impairs DNA repair in normal human oral keratinocytes.

Liu X, Nishitani J, McQuirter JL, Baluda MA, Park NH.

Cell Mol Biol (Noisy-le-grand). 2001 Nov;47(7):1169-78.

PMID:
11838964
7.

[Aberrations of the p53 antioncogene in malignant tumors].

Bártek J, Stasková Z, Lukás J, Bártková J.

Cas Lek Cesk. 1992 Dec 4;131(24-25):737-40. Czech.

PMID:
1288875
8.

The Evolution of the Ribosomal Protein-MDM2-p53 Pathway.

Deisenroth C, Franklin DA, Zhang Y.

Cold Spring Harb Perspect Med. 2016 Dec 1;6(12). pii: a026138. doi: 10.1101/cshperspect.a026138.

PMID:
27908926
9.

Two internal ribosome entry sites mediate the translation of p53 isoforms.

Ray PS, Grover R, Das S.

EMBO Rep. 2006 Apr;7(4):404-10. Epub 2006 Jan 20.

10.

Directed evolution of p53 variants with altered DNA-binding specificities by in vitro compartmentalization.

Fen CX, Coomber DW, Lane DP, Ghadessy FJ.

J Mol Biol. 2007 Aug 31;371(5):1238-48. Epub 2007 Jun 9.

PMID:
17610896
11.

The interaction of p53 with 3'-terminal mismatched DNA.

Bakhanashvili M, Hizi A, Rahav G.

Cell Cycle. 2010 Apr 1;9(7):1380-9. Epub 2010 Apr 1.

PMID:
20372060
12.

p53-based anti-cancer therapies: An empty promise?

Desilet N, Campbell TN, Choy FY.

Curr Issues Mol Biol. 2010;12(3):143-6. Epub 2009 Nov 16.

13.

JMJD5 interacts with p53 and negatively regulates p53 function in control of cell cycle and proliferation.

Huang X, Zhang S, Qi H, Wang Z, Chen HW, Shao J, Shen J.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2286-95. doi: 10.1016/j.bbamcr.2015.05.026. Epub 2015 May 27.

14.

Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D.

Krześniak M, Zajkowicz A, Matuszczyk I, Rusin M.

Mech Ageing Dev. 2014 Jul;139:11-21. doi: 10.1016/j.mad.2014.06.002. Epub 2014 Jun 8.

PMID:
24915467
15.

Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic β-cell function in diabetes.

Hoshino A, Ariyoshi M, Okawa Y, Kaimoto S, Uchihashi M, Fukai K, Iwai-Kanai E, Ikeda K, Ueyama T, Ogata T, Matoba S.

Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3116-21. doi: 10.1073/pnas.1318951111. Epub 2014 Feb 10.

16.

p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice.

Velasco-Hernández T, Vicente-Dueñas C, Sánchez-García I, Martin-Zanca D.

Cell Cycle. 2013 Jan 1;12(1):122-32. doi: 10.4161/cc.23031. Epub 2012 Dec 19.

17.

Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.

Cheng JC, Auersperg N, Leung PC.

Oncogene. 2011 Mar 3;30(9):1020-31. doi: 10.1038/onc.2010.486. Epub 2010 Oct 25.

PMID:
20972462
18.

Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.

Menendez D, Inga A, Resnick MA.

Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1500-5. doi: 10.1073/pnas.0909129107. Epub 2010 Jan 4.

19.

p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells.

Bhana S, Hewer A, Phillips DH, Lloyd DR.

Mutagenesis. 2008 Mar;23(2):131-6. doi: 10.1093/mutage/gen001. Epub 2008 Feb 10.

PMID:
18267949
20.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413

Supplemental Content

Support Center